Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Insulin Delivery System Market by Type (Insulin Syringes, Insulin PumpS, Insulin Pens), By Application (Hospitals, Home Care) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Insulin Delivery System Market by Type (Insulin Syringes, Insulin PumpS, Insulin Pens), By Application (Hospitals, Home Care) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 196938 3300 Medical Devices & Consumables 377 246 Pages 4.9 (30)
                                          

The global insulin delivery system market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. Insulin delivery systems are used for the treatment of diabetes mellitus and other conditions that require insulin therapy. Insulin delivery systems are classified into three types: insulin syringes, insulin pumps, and insulin pens. The application segment includes hospitals and home care. The global market is dominated by North America followed by Europe, Asia Pacific, Latin America and Middle East & Africa respectively in terms of revenue contribution in 2017.

Some Of The Growth Factors Of This Market:

  1. Insulin delivery systems are used for treating diabetes mellitus type 1 and type 2 patients who cannot produce or use insulin on their own due to various reasons such as genetic defects or autoimmune disorders that destroy beta cells in pancreas which produce insulin naturally.
  2. Insulin delivery systems are also used for treating gestational diabetes mellitus (GDM) during pregnancy when pregnant women need more insulin than usual because they have high blood sugar levels during pregnancy but do not have diabetes before becoming pregnant or after giving birth . GDM can cause serious health problems for both mother and baby if left untreated, including preeclampsia, preterm birth, stillbirths, and babies with low birth weight (less than 5 pounds). Gestational Diabetes Mellitus affects about 3-5% of all pregnancies worldwide with an estimated incidence rate of 6-8% in North America alone.

Industry Growth Insights published a new data on “Insulin Delivery System Market”. The research report is titled “Insulin Delivery System Market research by Types (Insulin Syringes, Insulin PumpS, Insulin Pens), By Applications (Hospitals, Home Care), By Players/Companies BD, Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet, Insulet, MannKind, Owen Mumford, Roche, SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Insulin Delivery System Market Research Report

By Type

Insulin Syringes, Insulin PumpS, Insulin Pens

By Application

Hospitals, Home Care

By Companies

BD, Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet, Insulet, MannKind, Owen Mumford, Roche, SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Insulin Delivery System Industry Outlook


Global Insulin Delivery System Market Report Segments:

The global Insulin Delivery System market is segmented on the basis of:

Types

Insulin Syringes, Insulin PumpS, Insulin Pens

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Home Care

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BD
  2. Novo Nordisk
  3. Sanofi
  4. Eli Lilly
  5. Medtronic
  6. Animas
  7. Beta Bionics
  8. Cellnovo
  9. Copernicus
  10. Dance Biopharm
  11. Debiotech
  12. InsuJet
  13. Insulet
  14. MannKind
  15. Owen Mumford
  16. Roche
  17. SHL
  18. SOOIL
  19. Tandem Diabetes Care
  20. Valeritas
  21. West Pharma
  22. Ypsomed

Global Insulin Delivery System Market Overview


Highlights of The Insulin Delivery System Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Insulin Syringes
    2. Insulin PumpS
    3. Insulin Pens
  1. By Application:

    1. Hospitals
    2. Home Care
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Insulin Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Insulin Delivery System Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Insulin delivery system refers to the various technologies used to inject insulin into a patient's body. These systems can be divided into two categories: traditional and pump-based.

Some of the major companies in the insulin delivery system market are BD, Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet, Insulet, MannKind, Owen Mumford, Roche, SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed.

The insulin delivery system market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Insulin Delivery System Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Insulin Delivery System Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Insulin Delivery System Market - Supply Chain
   4.5. Global Insulin Delivery System Market Forecast
      4.5.1. Insulin Delivery System Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Insulin Delivery System Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Insulin Delivery System Market Absolute $ Opportunity

5. Global Insulin Delivery System Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Insulin Delivery System Market Size and Volume Forecast by Type
      5.3.1. Insulin Syringes
      5.3.2. Insulin PumpS
      5.3.3. Insulin Pens
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Insulin Delivery System Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Insulin Delivery System Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Home Care
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Insulin Delivery System Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Insulin Delivery System Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Insulin Delivery System Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Insulin Delivery System Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Insulin Delivery System Demand Share Forecast, 2019-2026

9. North America Insulin Delivery System Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Insulin Delivery System Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Insulin Delivery System Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Home Care
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Insulin Delivery System Market Size and Volume Forecast by Type
      9.7.1. Insulin Syringes
      9.7.2. Insulin PumpS
      9.7.3. Insulin Pens
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Insulin Delivery System Demand Share Forecast, 2019-2026

10. Latin America Insulin Delivery System Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Insulin Delivery System Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Insulin Delivery System Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Home Care
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Insulin Delivery System Market Size and Volume Forecast by Type
      10.7.1. Insulin Syringes
      10.7.2. Insulin PumpS
      10.7.3. Insulin Pens
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Insulin Delivery System Demand Share Forecast, 2019-2026

11. Europe Insulin Delivery System Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Insulin Delivery System Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Insulin Delivery System Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Home Care
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Insulin Delivery System Market Size and Volume Forecast by Type
      11.7.1. Insulin Syringes
      11.7.2. Insulin PumpS
      11.7.3. Insulin Pens
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. -o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Insulin Delivery System Demand Share, 2019-2026

12. Asia Pacific Insulin Delivery System Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Insulin Delivery System Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Insulin Delivery System Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Home Care
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Insulin Delivery System Market Size and Volume Forecast by Type
      12.7.1. Insulin Syringes
      12.7.2. Insulin PumpS
      12.7.3. Insulin Pens
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Insulin Delivery System Demand Share, 2019-2026

13. Middle East & Africa Insulin Delivery System Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Insulin Delivery System Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Insulin Delivery System Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Home Care
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Insulin Delivery System Market Size and Volume Forecast by Type
      13.7.1. Insulin Syringes
      13.7.2. Insulin PumpS
      13.7.3. Insulin Pens
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Insulin Delivery System Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Insulin Delivery System Market: Market Share Analysis
   14.2. Insulin Delivery System Distributors and Customers
   14.3. Insulin Delivery System Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BD
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novo Nordisk
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Sanofi
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Eli Lilly
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Medtronic
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Animas
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Beta Bionics
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Cellnovo
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Copernicus
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Dance Biopharm
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Debiotech
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. InsuJet
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Insulet
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. MannKind
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Owen Mumford
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Roche
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. SHL
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. SOOIL
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Tandem Diabetes Care
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Valeritas
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us